Altieri calls for cross-party cooperation among lawmakers and researchers to establish a durable funding environment that prevents cyclical disruptions to biomedical progress.

A PA coalition of scientific research institutions and advocacy groups is urging Congress to increase NIH funding as the federal shutdown ends, stressing the need for stable biomedical research support across the state.

The coalition, including the American Association for Cancer Research, the Pennsylvania Biotechnology Center, and the University City Science Center, frames NIH funding as essential across multiple research domains and institutions throughout Pennsylvania.

The Ad Hoc NIH Funding Advocacy Coalition in Pennsylvania is seeking NIH funding of $47.2 billion in the upcoming fiscal year, which would be a $400 million increase rather than implementing a 40% cut proposed by the administration.

Wistar Institute’s leadership warns that previous shutdown-related pauses disrupted research activity, illustrating the broader impact on PA research campuses.

University of Pennsylvania and Children’s Hospital of Philadelphia were initial signatories to the coalition’s first letter, and CHOP and Penn continue advocacy efforts even as the second letter’s signatories shifted.

CHOP and Penn have engaged in direct advocacy in Washington, D.C., with staff traveling to meet lawmakers to stress NIH funding’s importance for saving lives and advancing cures.

Leading PA institutions, including CHOP and Penn, back NIH funding and remain actively involved in advocacy to secure federal support.

Philadelphia’s biomedical community, led by Wistar Institute president Dario Altieri, is calling on Congress to boost NIH funding as budget talks resume after the shutdown.

Funding uncertainty this year led to canceled or delayed NIH grant proposals, hampering progress at institutions like Wistar.

Pennsylvania’s Ad Hoc NIH Funding Advocacy Coalition urges the $47.2 billion level for NIH next year to avoid deep cuts and support ongoing research.

Altieri argues NIH funding is a bipartisan imperative for Pennsylvanians, urging stable, predictable support amid year-long research uncertainties.